Based on the significant role of the KRAS mutation in pancreatic cancer, these results confirm the potential role of MIR31HG in the malignant transformation of different tumors, including KRAS-driven pancreatic cancer. This evidence concerns the gene KRAS and familial pancreatic carcinoma.